角膜内皮毒性二次到局部的5-甲
Ahmed Alsaleh1, Abdulrahman Alfarhan1
1Anterior Segment Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Middle East African journal of ophthalmology
|March 4, 2024
概括
局部使用的5-fluorouracil (5-FU) 用于治疗眼睛发育不良. 这项研究报告了用5-FU治疗的患者显著的角膜内皮变化,挑战了其假定的安全性.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 5-甲 (5-FU) 是一种用于结膜和角膜发育不良的化疗剂.
- 以前的研究表明,长期眼部使用5-FU是安全的,对角膜内皮没有细胞毒性作用.
研究的目的:
- 要报告双侧眼表面状瘤病例,用5-甲治疗.
- 为了调查角膜内皮细胞密度和形态在局部5-FU管理后的潜在变化.
- 评估局部5-FU对角膜内皮的长期安全性.
主要方法:
- 一个患者的病例报告,双侧眼表面状瘤.
- 治疗包括一次局部5-甲的疗程.
- 在治疗前和治疗后评估了角膜内皮细胞密度和形态.
主要成果:
- 患者在5-FU治疗后出现角膜内皮细胞密度和形态的显著变化.
- 这些发现与之前的报告相反,这些报告表明局部5-FU对角膜内皮没有细胞毒性作用.
- 观察到的变化引发了人们对特定患者群体中5-FU的长期安全性的担忧.
结论:
- 局部使用的5-fluorouracil可能会在患有眼表面状瘤的患者中诱导显著的角膜内皮变化.
- 需要进一步的研究来了解5-FU诱导的内皮毒性的机制和长期影响.
- 临床医生应仔细监测眼皮表面疾病的5-FU治疗患者的角膜健康状况.
更多相关视频
09:31Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
Published on: July 22, 2021
2.1K
04:00Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024
1.9K
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.4K
Drug Toxicity: Allergic Reactions
223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Cytotoxic Edema: Pathophysiology
31
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
31
